title: Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab.
authors.forename: F
authors.initials: F
authors.lastname: Ursini
authors.forename: E
authors.initials: E
authors.lastname: Succurro
authors.forename: A
authors.initials: A
authors.lastname: Grembiale
authors.forename: S
authors.initials: S
authors.lastname: Rudi
authors.forename: R D
authors.initials: RD
authors.lastname: Grembiale
authors.forename: F
authors.initials: F
authors.lastname: Arturi